2022
DOI: 10.1007/s40135-022-00285-5
|View full text |Cite
|
Sign up to set email alerts
|

Platelet Lysate as a Promising Medium for Nanocarriers in the Management and Treatment of Ocular Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 207 publications
0
1
0
Order By: Relevance
“…Nanotherapeutics overcome the limitations and reduce side effects by their high specificity, biocompatibility, enhanced permeability retention, and increased host immunological response [12]. There are several nanodrug delivery systems available [13,14]. This delivery system (i) can incorporate both hydrophobic and hydrophilic drugs, (ii) can be administered through any route like nasal, ocular, oral, etc., (iii) increases the shelf life of drugs, and (iv) improves drug bioavailability [15].…”
Section: Introductionmentioning
confidence: 99%
“…Nanotherapeutics overcome the limitations and reduce side effects by their high specificity, biocompatibility, enhanced permeability retention, and increased host immunological response [12]. There are several nanodrug delivery systems available [13,14]. This delivery system (i) can incorporate both hydrophobic and hydrophilic drugs, (ii) can be administered through any route like nasal, ocular, oral, etc., (iii) increases the shelf life of drugs, and (iv) improves drug bioavailability [15].…”
Section: Introductionmentioning
confidence: 99%